Copy number variations (CNVs) contribute to neuropsychiatric diseases, which may be partly mediated by their effects on gene expression. However, few studies have assessed the influence of CNVs on gene expression in the brain. The objective was to perform an unbiased comprehensive survey of influence of CNVs on gene expression in human brain tissues. CNV regions (CNVRs) were identified in 72 individuals (23 schizophrenia, 23 bipolar disorder and 26 controls). Significant associations between the CNVRs and gene expression levels were observed for 583 CNVR-expression probe pairs (293 unique eCNVRs and 429 unique transcripts), after corrections for multiple testing and controlling the effect of the number of subjects with CNVRs by label swapping permutations. These CNVRs affecting gene expression (eCNVRs) were significantly enriched for rare/low frequency (p = 1.087 × 10 −10 ) and gene-harboring CNVRs (p = 1.4 × 10 −6 ). Transcripts overlapping CNVRs were significantly enriched for glutathione metabolism and oxidative stress only for cases but not for controls. Moreover, 72 (24.6%) of eCNVRs were located within the chromosomal aberration regions implicated in psychiatric-disorders: 16p11.2, 1q21.1, 22q11.2, 3q29, 15q11.2, 17q12 and 16p13.1. These results shed light on the mechanism of how CNVs confer a risk for psychiatric disorders.
Introduction
A key objective in genetic research is to link genomic variation to phenotype differences to uncover normal as well as pathological variation. The influence of single nucleotide polymorphisms on phenotypic variation has been extensively studied; however, it is only recently that other DNA alterations such as copy number variations are being investigated. Copy number variations (CNVs) are DNA segments present at variable copy numbers and owing to their large size, contribute to a substantial proportion of the variation in the human genome (Ionita-Laza et al., 2009; Redon et al., 2006) . Among the CNVs, rare CNVs are of more interest because they are presumably enriched in de novo events. Under the rare-variant common disease hypothesis, multiple rare variants with high effect sizes in aggregation, contribute substantially to the illness, hence these rare variants are of great interest since they have not been subject to selection as yet (Zhang et al., 2009) . Rare copy number variations have been reported in individuals with neurological and psychiatric disorders such as schizophrenia (International Schizophrenia Consortium, 2008; Levinson et al., 2011; McCarthy et al., 2009) , autism (Hedges et al., 2012) , bipolar disorder (Zhang et al., 2009 ) and mental retardation (Guilmatre et al., 2009) .
Although a large number of CNVs have been identified in a variety of different species and range of diseases, the functional impact of CNVs at the molecular level remains largely unexplored. One way to assess the functional impact of copy number variations is via its effect on different cellular processes such as gene expression levels. The initial study exploring the transcriptome-wide impact of CNVs on gene expression profiles in lymphoblastoid cell lines (LCLs) identified that approximately 20% of variation in gene expression could be attributed to copy number variations in the genome (Stranger et al., 2007) . While there is a plethora of studies assessing the influence of single nucleotide polymorphisms on gene expression profiles, to the best of our knowledge, there are only four studies interrogating the influence of CNVs on gene expression in humans. Moreover, due to the limited availability of human tissues such as brain samples, three of the four studies assessing the influence of CNVs on gene expression in normal tissues till date have been performed on LCLs (Luo et al., 2012; Schlattl et al., 2011; Stranger et al., 2007) while only one recent study (Ye et al., 2012) has assessed gene expression in the human brain.
Integration of gene expression and CNV data will allow the prioritization of CNV-harboring candidate regions where the CNVs significantly alter gene expression levels of transcripts thereby providing evidence of a downstream functional consequence. The aim of this study was to perform a comprehensive and unbiased genome-wide search for functional CNVs in the human brain and to interrogate the nature of these CNVs.
Materials and methods

Samples
Gene expression and copy number variations (CNVs) were obtained from prefrontal cortices of postmortem brains of 105 individuals (35 controls, 35 bipolar disorder [one of which was later excluded due to the alteration of diagnosis] and 35 schizophrenia patients) from the Stanley Medical Research Institute. As described in our previous report (Iwamoto et al., 2011) , to reduce confounding factors due to previously identified effects of sample pH, we interrogated 72 individuals (26 controls, 23 bipolar disorder and 23 schizophrenia patients) which were preselected for high pH levels (pH ≥ 6.4).
Gene expression
Gene expression levels were assessed using the Affymetrix HU133A microarray which comprised of 22,283 expression probes, details of which are described elsewhere (Iwamoto et al., 2011) . Briefly, the raw gene expression data was preprocessed using MAS5 (Affymetrix) and filtered for probes which were called present in more than 50% of the samples, allowing a total of 11,920 probes for subsequent analysis. Microarray data had been deposited to the GEO database and is available on the GEO server (GES12649) and on the Stanley Medical Research Institute database (https://www.stanleygenomics.org/).
Copy number variation
Copy number variation was measured on the Agilent 450k early access CGH array (Agilent Technologies, Inc., Santa Clara, CA, USA), which is designed based on the database of known CNVs. Sample and reference DNA (3.0 g each) was labeled with Cy5 or Cy3 using the DNA labeling kit from Agilent. Hybridization and washes were performed following the manufacturer's recommendation. The arrays were scanned with a MicroArray Scanner G2505A (Agilent). The obtained TIFF image data were processed with Agilent Feature Extraction software (version 9.5.3.1) using the CGH-v4 95 Feb07 protocol (Agilent).
DNA from one female (NA15510, Coriell Cell Repository, Camden, NJ, USA) was used as a reference to allow detection of copy number changes. This was in accordance with previous reports which have shown that usage of a single reference increases the sensitivity to detect more CNVs and produces more consistent and reproducible data as compared to using a pooled reference (Haraksingh et al., 2011) . The raw data were imported into Agilent DNA Analytics 70 software and analyzed using the Aberration Detection Method 2 (ADM-2) algorithm (Lipson et al., 2006) which uses log2 ratios weighted by log2 ratios error as calculated by Feature Extraction software to identify genomic intervals with copy number differences between the samples and the reference. The Agilent Feature Extraction software was used to compute Quality Control metrics. The Agilent protocol recommended thresholds including average signal intensity at each probe, background signal (noise) (<5) using non-hybridizing control probes and signal-tonoise ratios (>30) were used to assess the quality of DNA and the experimental workflow. The derivative log ratio spread (dLRsd) was used to calculate the robust standard deviation (spread) of the log ratio differences between consecutive probes across all chromosomes. Three samples that did not satisfy the QC metrics thresholds and had dLRsd of >0.30 were excluded from further analysis.
The following parameters were used in this analysis: threshold of ADM-2: 6.0 with a bin size of 10; fuzzy zero: on; GC correction: on, aberration filters: on (maxAberrations = 100,000 AND percentPenetrance = 0); feature level filters: on (gIsSaturated = true OR rIsSaturated = true OR gIsFeatNonUnifOL = true OR rIsFeatNonUnifOL = true). A minimum three contiguous suprathreshold probes were mandatory to define a copy number change. Data were centralized and calls with average log2 ratios of ≤0.25 were excluded from the analysis. Data were normalized using the GC correction algorithm that corrects for wavy artifacts associated with the GC content of genomic regions and fuzzy zero correction that allows correction of extended aberrant segments with low absolute mean ratios that might represent noise. In the current study we assessed only autosomal CNVs since analysis of X and Y chromosomal CNVs are difficult to interpret. After filtering, a total of 34,453 CNV probes corresponding to 6836 copy number variable regions (CNVRs) were used for the analysis.
Statistical analysis
Physical positions and annotations of the gene expression and CNV array probes were updated to the Genome build GRCh37 (hg19) using the UCSC genome browser Liftover tool (http://genome.ucsc.edu/cgi-bin/hgLiftOver). Separate analysis was performed for the continuous log2 CNV ratio and the simplified CNV state (1 = loss, 2 = normal state and 3 = gain) for each CNVR. A log2 ratio of 0 was considered the normal state, a log2 ratio of <−0.25 was considered a loss and log2 ratio of >0.25 was considered a gain. To identify the influence of CNVRs on gene expression, for each CNVR we probed a cis-window of ±1 Mb from the CNVR coordinates. For all gene expression probes located fully or partially (at least 1 bp overlap) within this window, we calculated the association between the CNVR state/CNVR log-ratio and the gene expression levels using general linear models (glm) in R, whilst covarying for age, gender, ethnicity and post-mortem interval (PMI) hours and the results were corrected for multiple testing using 5% false discovery rate (fdr). Results of the association between the CNVR state/CNVR log-ratio and the gene expression levels were very similar, therefore only the results for the CNVR state are presented.
To correct for the different numbers of gene expression probes tested for each CNVR and to account for possible inflation in association p-values which might result due to outliers especially for the singletons, we repeated the association analysis using labelswapping adaptive permutations with a maximum of 100,000 permutations in PLINK (Purcell et al., 2007) . This method is widely accepted as the most appropriate method for multiple testing correction and allows for outlier detection (Gibbs et al., 2010; Luo et al., 2012) since it does not assume the normal distribution of the trait and calculates the empirical p-value by label-swapping of the quantitative trait by randomly assigning each individuals quantitative trait (gene expression level) to another individuals CNVR state. Results from all permutations are used to calculate an empirical p-value of significance for each CNVR-gene expression pair (Lanktree et al., 2009) .
Associations with p-values of ≤0.05 after 5% fdr correction and permutation empirical p-values of ≤0.05 were considered significant. Genomic inflation was assessed by calculation of the lambda (genomic inflation factor) for each CNVR in R. The proportion of variance in gene expression explained by the CNVR was calculated using the adjusted R 2 obtained by the glm function in R. Differences in gene expression variances across groups of transcripts were calculated using the 2-sided Kolmogorov-Smirnov test (KS-test). Enrichment of eCNVRs for low frequency and over-representation of genic eCNVRs was performed by conducting simulations. Simulations were performed by generating 1000 randomized CNVRs sets, matched for the CNVR frequency and of the same set at the eCNVR set. The randomized sets of CNVRs were sampled (without replacement) from all the tested CNVRs and based on the simulations we obtained empirical p-values for enrichment. All reported p-values were 2-sided and within 95% confidence interval.
Gene expression probes containing SNPs within their sequences were identified using the PLANdbAffy database (http://affymetrix2. bioinf.fbb.msu.ru) and are highlighted in the results table.
The functional analysis was performed using the Wikipathways and KEGG tools via the WebGestalt Gene Set Enrichment database (http://bioinfo.vanderbilt.edu/webgestalt/). The enrichment was calculated using a hypogeometric test using the human genome as the background and all results were corrected for multiple testing using the Bonferroni correction.
For comparisons of the results with previously reported eCNVRs (Luo et al., 2012; Schlattl et al., 2011; Stranger et al., 2007) , we used the eCNVRs which were significant at linear regression fdr of 5% and permutation empirical p-value of ≤0.05 and compared these to previously reported eCNVRs to check for overlaps between the data sets.
To compare our results with previously identified brain phenotype-associated CNVRs, we performed manual data mining using NCBI PubMed to search for articles reporting significant CNVs identified in schizophrenia, major depressive disorder, bipolar disorder and/or autism. We limited our search to 7 large association studies which comprised of at least 3000 patients each (Ingason et al., 2011; International Schizophrenia Consortium, 2008; Levinson et al., 2011; McCarthy et al., 2009; Moreno-De-Luca et al., 2010; Stefansson et al., 2008; Weiss et al., 2008) .
Results
Identification of CNVRs
A flowchart of the study design and results is provided in Fig. 1 . Sample characteristics of the 72 individuals included in the study are provided in Supplementary Table 1 . While results on the expression profiles of these samples have been reported previously (Iwamoto et al., 2005 (Iwamoto et al., , 2011 , in the current study we assessed the influence of CNVs on gene expression at the genome-wide scale. Using the Agilent early access 450k array, after filtering and preprocessing, a total of 34,453 autosomal CNVs were identified in the current samples, which were further grouped into 6836 unique copy number variable regions (CNVRs) using criteria of at least 3 overlapping CNV probes. Among the 6836 CNVRs, 3549 were losses, 3136 were gains and 151 were complex (gains in some and losses in others).
Of the CNVRs, 3656 (53.4%) were singletons while the remaining 3180 CNVRs were identified in at least two individuals (identical CNVR start and end coordinates). For statistical analysis purposes, the common criteria of 5% frequency was used to group the CNVRs into 5058 (74%) rare/low frequency CNVRs and 1778 common CNVRs (26%). Further, CNVRs were divided into two categories; genic and intergenic. A total of 3051 of 6836 CNVRs (44.6%) were 'genic' CNVRs, i.e. CNVRs spanning a part of whole of the transcript gene expression probe (with at least one base pair overlap between the regions) while the remaining CNVRs did not harbor any known transcripts. The mean and median CNVR size was 66.5 kb and 11.9 kb respectively with average CNV segment numbers of 688 across all samples. The total combined CNVR burden across the individuals ranged between 11.6 and 72.4 Mb. The total number of CNVR calls and distribution of CNVR length and probes encompassing CNVRs are depicted in Fig. 2 .
Gene expression
Influence of CNVRs on gene expression
Next, we sought to assess the influence of CNVRs on gene expression profiles in the human prefrontal cortex to identify functional CNVRs. To test the influence of CNVRs on the neighboring transcripts we defined a cis window of ±1 Mb from the CNVR to identify proximal transcripts (Fig. 3 ). For 6219 of the 6836 unique CNVRs, at least one transcript was located within the ±1Mb CNVR cis coordinates. Transcripts located within the cis coordinates amounted to a total of 12,718 unique transcripts. For each CNVR, we tested the association between the CNVR and the transcripts within the cis coordinates using general linear models and adjusting for age, gender and PMI hours for the CNVR state. All results were corrected for multiple testing using 5% fdr. To avoid inflation due to outliers, we repeated the association analysis by label-swapping adaptive permutations for each CNVR-expression probe pair. Results of the permutations were compared with the linear regression results and only CNVR-expression probe pairs significant in both tests were deemed as significant. Average genomic inflation factor across all tested transcripts was 1.06, indicating no apparent inflation.
A total of 4201 CNVR-probe pairs were significant at p ≤ 0.05 and a total of 707 CNVR-probe pairs were significant at 5% fdr threshold in the linear regression analysis. These 707 pairs corresponded to a total of 339 unique expression CNVRs (expression-influencing CNVRs or eCNVRs) and 448 unique expression probes. Of these, 583 CNVR-probe pairs (293 unique eCNVRs and 429 unique expression probes) were also significant after permutation testing (Supplementary Table 2 ). Representative examples of box plots of associations between CNVRs and gene expression profiles of significant eCNVRs are depicted in Fig. 4 and a list of the top 15 associations is given in Table 1 . Therefore, expression levels of 429 (3.4%) of 12,718 tested transcripts were significantly influenced by CNVRs after stringent corrections for multiple testing and permutation. For 15 CNVRs overlapping a transcript (inside pairs), a positive correlation between CNV state and gene expression was obtained, as expected. On the other hand, a certain part of CNVR-gene expression correlations were negative. Such non-conventional types of eCNVRs seen in 242 (41%) of the 293 CNVRs in this study have also been reported in previous studies (Luo et al., 2012; Schlattl et al., 2011; Stranger et al., 2007) .
Nature of the significant brain eCNVRs
Of the 583 CNVR-probe pairs, we next interrogated the nature of the 293 unique CNVRs in terms of frequency, size, genes harbored, proportion of variance explained and functional annotation (see Supplementary Table 2 ). Of the 293 eCNVRs, 239 (81.6%) were rare/low frequency (<5% MAF) and the remaining 54 (18.4%) were common eCNVRs. There was a significant over-representation of rare/low frequency CNVRs among the significant eCNVRs (p = 1.087 × 10 −10 ). The size of the CNVRs ranged between 234 bp and 1.65 Mb, with an average length of 0.73 Mb. Summary of the CNVR lengths are as follows; -≤100 kb: 237, 101-500 kb: 48, 501 kb to 1 Mb: 7, and >1 Mb: 1. Of the significant eCNVRs, 179 (61.1%) were genic while the remaining 38.9% were non-genic, corresponding to a significant over-representation of genic CNVRs among the eCNVRs (p = 1.4 × 10 −6 ). Such significant enrichment of low frequency and genic CNVRs was also observed when the analysis was restricted to non-singleton CNVRs (CNVRs robustly detected in at least 2 individuals) and when the CNVRs were restricted to CNVR intervals containing at least 5 or more probes. Consistent with previous reports, no significant correlations between CNVR-probe distance and frequency of significant eCNVRs or the p-value of the association was observed. Such correlation was not seen even when stratifying the samples into low/high frequency CNVRs and genic/non-genic CNVRs (p > 0.05). The average proportion of variance in gene expression explained by the eCNVR was 26% across all significant CNVR-probe pairs.
Validation of the CNVRs and gene expression
We next compared the brain eCNVRs to previously reported eCNVRs in lymphoblast cell lines (Luo et al., 2012; Schlattl et al., 2011; Stranger et al., 2007) or in the prefrontal cortex (Ye et al., 2012) . Of the 293 eCNVRs, 29 (10%) were previously reported to influence gene expression of nearby transcripts (see Supplementary Table 2 ).
Next, we compared the copy number data obtained by Agilent CNV array with those obtained by Affymetix GeneChip Human Mapping 500k SNP arrays for technical validation, which we have described previously (Iwamoto et al., 2011) . Of the 731 autosomal CNVRs detected on the SNP array, we were able to detect 68 (9.3%) on the CNV array, these included 2 singleton eCNVRs which were significantly associated with gene expression (see Supplementary  Table 2 ).
For validation of gene expression data, we used previously reported data from Altar et al. (2008) , where gene expression profiling for the same prefrontal cortex samples was performed using the same arrays and the same normalization protocols. We assessed the correlations between the gene expression profiles from the current dataset and the published dataset. For the 429 probes significantly associated with CNVRs from Supplementary Table 2, an average correlation of 0.43 and median correlation of 0.40 was observed across all individuals. Using gene expression levels from Altar and colleagues, we were able to successfully replicate CNVRgene expression associations for a handful of selected transcripts including PTPRN2, FHL2, SLC16A1, CH1DL and COMT genes, thereby demonstrating the technical reliability of the data (see Supplementary Table 2 ).
Overlap with loci associated with psychiatric disorders
While the eCNVR analysis was performed across all individuals due to limited power, the samples comprised of individuals with bipolar disorder (n = 23), schizophrenia (n = 23) and controls (n = 26). Of the 293 significant eCNVRs, 49 CNVRs were found only in bipolar disorder patients, 72 CNVRs were found only in schizophrenia patients, 70 CNVRs were found only in controls and the remaining 122 CNVRs were found in individuals belonging to two or more groups. The average CNVR burden and number of CNVRs were 32.23 kb and 621 regions in schizophrenia patients, 32.81 kb and 623 regions in bipolar patients and 30.12 kb and 588 regions in controls. No significant differences between the total CNVR burden, average CNVR burden and number of CNVRs were observed across the groups.
Functional annotation of CNVR-influenced genes
Next, we interrogated the functional relevance of the significant CNVR-gene expression pairs using the Web-based Gene Set Enrichment analysis (WebGestalt -Wikipathways and KEGG tools).
Among transcripts whose expression was significantly influenced by CNVRs, the corticotropin-releasing hormone pathway was significantly enriched and this enrichment was also observed when stratifying transcripts influenced by CNVRs in cases only or in controls only (Table 2) .
Functional annotation of genes overlapping copy number variants identified a significant enrichment of transcripts implicated within glutathione metabolism (p = 0.020) and oxidative stress (p = 0.030) pathways in all genes (p = 0.020) and also only among genes overlapping CNVRs in cases only (p = 0.0015 for glutathione metabolism and p = 0.0031 for oxidative stress) but no such enrichment was observed when assessing only genes overlapping CNVRs in controls only.
Hence, the functional relevance of the CNVR-encompassed transcripts seems to be different in cases versus controls.
Comparison with loci associated with psychiatric disorders
We next compared the brain eCNVRs to previously reported loci containing CNVRs which were shown to be associated with schizophrenia, major depressive disorder, bipolar disorder and/or autism (Supplementary Table 2 ). We limited our search to loci from 7 large association studies (8 unique loci: 16p11.2, 1q21.1, 22q11.2, 3q29, 17q12, 16p13.1, 15q13.3 and 15q11.2) comprising of over 3000 cases per study. These 8 loci spanned approximately 44.6 Mb (∼1.4% of whole genome). Of the 293 significant eCNVRs, 72 (24.6%) psychiatric-disorder associated CNVRs were found (Table 3) . Of the 72 CNVRs, 19 were found only in schizophrenia patients, 21 were found only in bipolar disorder patients and 19 were found only in controls. Of the 19 CNVRs found only in controls, 7 were found in a single control individual (C 15), due to unknown or unexplained reasons, while the remaining CNVRs were found in independent individuals. The average number of CNVRs and total CNVR burden in this individual was well within the normal range (see Fig. 2b control 15) and we technically validated two singleton CNVRs in this individual (see Supplementary Table 2) , thereby reducing the possibility of sample issues such as DNA quality or hybridization problems.
The 72 eCNVRs spanned seven of the eight candidate regions including 16p11.2, 1q21.1, 22q11.2 (see Fig. 5 ), 3q29 (see Fig. 5 ), 15q11.2, 17q12 and 16p13.1 (Fig. 6 and Table 3 ). In a recent study, CNVRs in 1q21.1 and 22q11.2 were shown to be significantly associated with dorsolateral prefrontal cortex gene expression levels of nearby transcripts (Ye et al., 2012) while the other regions, to the best of our knowledge, has not been shown to have functional influence on gene expression regulation in the human brain.
Discussion
In the current study, we interrogated the influence of CNVs on gene expression in prefrontal cortex of post-mortem brain samples to identify functional CNVs. Gene expression levels of Table 3 List of eCNVRs within psychiatric trait-associated loci (International Schizophrenia Consortium, 2008; Levinson et al., 2011; McCarthy et al., 2009; Moreno-De-Luca et al., 2010; Stefansson et al., 2008 x = in LCLs and xxx = in brain tissue; sz = schizophrenia, bp = bipolar, con = control, con* = control outlier C 15.
Fig. 5.
Significant eCNVRs previously shown to be associated with schizophrenia or autism-spectrum disorders within candidate loci 3q29 and 22q11.2. 429 transcripts were significantly associated with CNVR state after corrections for multiple testing and permutation. This corresponded to 583 CNVR-probe pairs (293 unique eCNVRs). Among the eCNVRs, a significant over-representation of rare/low frequency CNVRs (p = 1.087 × 10 −10 ) and gene-harboring/genic CNVRs (p = 1.4 × 10 −6 ) was observed. Overrepresentation of rare/low frequency CNVs among eCNVRs is interesting from an evolutionary point of view. A significant proportion of variance in gene expression could be explained by the eCNVR, with an average of 26% variance across the transcripts. A large proportion of negative correlations observed, demonstrated the complex relationship between CNVs and gene expression. Regulatory mechanisms such as epistasis or auto-regulatory feedback mechanisms at the level of the gene might explain the negative correlations. For instance, deletions that affect silencers or insulator elements can result in increased gene expression of the transcript (Weischenfeldt et al., 2013) . Comparisons of the brain eCNVRs identified in the current study to previously reported eCNVRs yielded a 10% overlap, thereby providing a replication for these eCNVRs despite the differences in samples and study design between the studies. Functional annotation of transcripts associated with CNVRs revealed a significant enrichment of corticotrophin-releasing hormone pathway across all samples, and also upon stratification by cases and controls. However, genes overlapping CNVRs only in cases but not in controls were enriched for glutathione metabolism and oxidative stress. Glutathione is a major antioxidant in the brain and plays a crucial role in protecting against oxidative damage. It is reported that glutathione levels were decreased (Gawryluk et al., 2001 ) and oxidative stress is enhanced (Ng et al., 2008) in schizophrenia and bipolar disorder, and mood stabilizers increases glutathione S-transferase (Wang et al., 2004) . Thus, altered glutathione and oxidative stress pathways due to CNV might be related to pathophysiology of bipolar disorder and schizophrenia.
To test whether the eCNVRs were located within psychiatric phenotype-associated loci, we performed a literature search to identify CNVRs robustly associated with psychiatric diseases and systematically checked these loci (n = 8 unique loci). The 293 significant eCNVRs identified in this study included 72 (24.6%) psychiatric-disorder associated eCNVRs within these 8 loci, indicating that copy number variants in these loci might be directly involved in transcriptional regulation in the brain. These eCNVRs encompassed 7 (16p11.2, 1q21.1, 22q11.2, 3q29, 15q11.2, 17q12 and 16p13.1) of the 8 tested loci. Of the 72 eCNVRs, 19 CNVRs were identified only in schizophrenia patients and 21 CNVRs were observed only in bipolar disorder patients. A total of 19 CNVRs were found only in controls of which 7 were found in a single control individual (C 15). For C 15, the CNVR burden was within the range of that detected across all other samples and by technically validating two CNVRs harbored by this individual, we excluded the possibility of sample contamination or hybridization artifacts. This control individual however due to unknown or unexplained reasons harbored several of the known bipolar disorder and schizophrenia-associated CNVRs. For the 15q13.3 region, we did not identify any CNVRs associated with gene expression levels.
Recently, Ye and colleagues identified that CNVs in 1q21.1 and 22q11.2 were significantly associated with expression levels of nearby transcripts in dorsolateral prefrontal cortex (Ye et al., 2012) . We found an association between a CNVR in 1q21.1 and CHD1L as reported by Ye and colleagues and in the current study the same CNVR was also associated with gene expression levels of FMO5, PRKAB2, RNF115 and ITGA10. These CNVRs were present in 2 bipolar disorder patients and control C 15. Additionally, we identified 8 further CNVRs in 1q21.1 (6 only in bipolar patients, one in 2 bipolar patients, one control and control C 15 and one only in control C 15) significantly associated with gene expression levels of PDE4DIP, SEC22B, RBM8A, PRKAB2 and ITGA10. In line with Ye et al. (2012) , we observed a significant association of a 22q11.2 CNVR in control C 15 with COMT gene expression for two separate gene expression probes. In addition, our data pointed also toward the PI4KA gene within this locus whose expression was significantly associated with 2 CNVRs (both in control C 15) in the 22q11.2 locus. The initial study by Saito and colleagues (Saito et al., 2003) identified a link between PI4KA and 22q11.2-linked psychiatric disorders. The PI4KA gene encodes a phosphatidylinositol (PI) 4-kinase which catalyses the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. Incorporating the results of all association of PI4KA with schizophrenia till date has yielded mixed results and the link between PI4KA and psychiatric disorders remains unclear (Kanahara et al., 2009; Saito et al., 2003; Vorstman et al., 2009) . This is the first report highlighting a functional link between CNVRs within the 22q11.2 locus and PI4KA gene expression in the human brain, suggesting that PI4KA might indeed be related to 22q11.2-related psychiatric diseases. In summary, results of the current study replicate the findings by Ye and colleagues that 1q21.1 and 22q11.2 may be involved in pathophysiology of psychiatric disorders by affecting gene expression levels in the brain.
For an additional five candidate regions reported to be associated with schizophrenia and/or autism-spectrum disorders (3q29, 15q11.2, 16p11.2, 16p13.1 and 17q12), for the first time we identified significant functional influence of CNVRs on prefrontal cortex gene expression, implicating that these loci confer a risk of psychiatric disorders by affecting gene expression in the brain. Of note was the finding of 6 CNVRs within the 16p11.2 locus that significantly influenced gene expression profiles of several transcripts including CORO1A, TAOK2, DOC2A, SEPHS2 and CDIPT transcripts in the human prefrontal cortex. Both deletions and duplications within the 16p11.2 region have been significantly associated with schizophrenia, autism and autism-spectrum disorders in several studies (Levinson et al., 2011; Luo et al., 2012; McCarthy et al., 2009; Weiss et al., 2008) .
The current study has several strengths and limitations. On one hand, due to the small sample size, the power of this study is limited and replication of these findings in larger cohorts is warranted. Nonetheless, several of the results reported in this study overlap with previous reports, hence for these findings our study provides a replication of the previous results. Furthermore, 9.3% of autosomal CNVRs detected on the SNP array were successfully detected in the same individuals using the CNV arrays, thereby providing a technical validation of these data. Also, we acknowledge that possible confounding effects of medication or smoking or other illness-related factors are difficult to account for and might influence the gene expression profiles. To the best of our knowledge this is the most comprehensive genome-wide CNV-gene expression association analysis performed so far and the first genome-wide hypothesis-free study assessing the influence of rare/low frequency CNVs on gene expression in the human brain. Other strengths of this study include assessment of brain tissue which is more relevant for psychiatric diseases and utilization of brain samples with high pH levels to increase reliability of the data.
In conclusion, we used a hypothesis-free approach to identify brain CNVRs which significantly influence genome-wide gene expression levels of nearby transcripts. Such an integrative approach is important to prioritize functional CNVs which exhibit downstream consequences at the gene expression level over other CNVs. This study demonstrates that CNVRs influencing gene expression in the human prefrontal cortex are significantly enriched for rare/low frequency CNVs and gene harboring CNVs. Our results replicate previous findings of associations at 1q21.1 and 22q11.2 regions and suggest the possible role of candidates within the 3q29, 15q11.2, 16p11.2, 16p13.1 and 17q12 loci in schizophrenia and bipolar disorder. Future studies surveying different types of genetic variation in diverse tissues are required to fully comprehend human phenotypic diversity and disease.
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